Shareholders of Galderma, the Swiss maker of skincare products including botox, launched a block trade on Monday night to ...

Letybo, manufactured by Hugel, is massively popular in Korea, where it’s called Botulax, says Roy Kim, MD, a board-certified ...

that is a rival to AbbVie/Allergan's wrinkle treatment Botox. If both new products reach their $1 billion-plus sales potential it would have a transformative effect on Galderma, which recorded ...

and uphold Galderma’s position at the forefront of aesthetic advancements.” RELAX is a phase IIIb, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate ...

In neuromodulators, the primary brand marketed by Galderma is Dysport or Azzalure in Europe. AbbVie is by far the leading player in the category with its brand Botox (with a market share of around ...

The Differin owner’s mini-games are aimed at addressing acne's emotional impact on Gen Z and Gen Alpha consumers ...

Trump has also threatened to impose tariffs on Europe. As most aesthetic companies produce in Europe, they and Galderma would be affected, Ornskov said. Galderma's results come almost a year after ...

The Galderma Aesthetic Injector Network (GAIN) – which celebrates its 10 th anniversary this year – is Galderma's long-established training platform designed to educate, inspire, and empower ...

Aesthetic advancements across Galderma’s portfolio Galderma will also present the latest data from across its Injectable Aesthetics portfolio, including updates on Restylane, Sculptra ...